One of the most widely-used asthma and breathing treatments for over 20 years is being taken off the shelves in 2024, potentially leaving patients, healthcare providers and insurers scrambling.
After Flovent, one of the most popular inhalers for treating childhood asthma, was discontinued this past January, some parents are reporting challenges in obtaining the generic versions of the ...
Flovent, one of the most commonly prescribed childhood asthma inhalers, is no longer being manufactured in the United States. This preventative medication is usually taken every day to help keep an ...
A popular corticosteroid inhaler used to treat asthma and other conditions is being discontinued, and despite generic versions now available, health experts are warning patients to plan ahead for ...
Editor's note: Dr. Edith Bracho-Sanchez is a primary care pediatrician, director of pediatric telemedicine and assistant professor of pediatrics at Columbia University Irving Medical Center. Flovent, ...
- The first and only family of digital, breath-actuated inhalers with built-in sensors that track inhaler events and measure inspiratory flow - Digihaler® app provides patients the ability to view and ...
A generic fluticasone-salmeterol (Wixela Inhub) maintenance inhaler was clinically equivalent to name-brand Advair Diskus for chronic obstructive pulmonary disease (COPD), a propensity score-matched ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果